scholarly article | Q13442814 |
P356 | DOI | 10.1159/000180176 |
P698 | PubMed publication ID | 4695164 |
P2093 | author name string | G Richard | |
R Hunt | |||
R Hackett | |||
D Levin | |||
R Cade | |||
M Pickering | |||
M Fregly | |||
J Free | |||
A DeQuesada | |||
A Holcomb | |||
D Shires | |||
E Schlein | |||
G Spooner | |||
L Juncos | |||
P433 | issue | 1 | |
P921 | main subject | lupus nephritis | Q1621830 |
azathioprine | Q18939 | ||
heparin | Q190016 | ||
P304 | page(s) | 37-56 | |
P577 | publication date | 1973-01-01 | |
P1433 | published in | The Nephron Journals | Q15745443 |
P1476 | title | Comparison of azathioprine, prednisone, and heparin alone or combined in treating lupus nephritis | |
P478 | volume | 10 |
Q68787306 | Acute renal failure in systemic lupus erythematosus |
Q54262288 | Azathioprine in the treatment of systemic lupus erythematosus. A three-year prospective study |
Q37799087 | Azathioprine, cyclophosphamide and chlorambucil |
Q40497391 | Clinical use of immunosuppressive drugs: part I |
Q34309764 | Combination treatment in autoimmune diseases: systemic lupus erythematosus. |
Q39536979 | Comparison of chlorambucil, azathioprine or cyclophosphamide combined with corticosteroids in the treatment of lupus nephritis |
Q33836469 | Corticosteroid-induced adverse psychiatric effects: incidence, diagnosis and management. |
Q38099203 | Corticosteroid-induced neuropsychiatric disorders: review and contrast with neuropsychiatric lupus |
Q37949332 | Current treatment recommendations for lupus nephritis |
Q38936244 | Do corticosteroids really alter mood? |
Q40624631 | Drug-induced depression. Incidence, avoidance and management. |
Q34311883 | Drug-induced mania |
Q34728554 | Drug-induced mania in the elderly |
Q41077261 | Fibrinogen catabolism in systemic lupus erythematosus |
Q67255123 | Heparin therapy in anti-basement membrane nephritis |
Q33452842 | Immunologic findings, thrombocytopenia and disease activity in lupus nephritis |
Q36269226 | Immunosuppressive Therapy in Rheumatic Disease |
Q40883177 | Immunosuppressive drug therapy in lupus nephritis |
Q57689077 | Immunosuppressive treatment for proliferative lupus nephritis |
Q52884561 | Limitations of randomized clinical trials to recognize possible advantages of combination therapies in rheumatic diseases. |
Q67444638 | Long-term azathioprine-corticosteroid therapy in lupus nephritis and idiopathic nephrotic syndrome |
Q40665188 | Lupus nephritis in childhood and adolescence |
Q42823544 | Monthly plasmapheresis for systemic lupus erythematosus with diffuse proliferative glomerulonephritis: a pilot study |
Q40469520 | Neuropsychiatric Manifestations of Systemic Lupus Erythematosus |
Q67337023 | On survivorship in the nephritis of systemic lupus erythematosus |
Q66952174 | Participation of Kallikrein, Coagulation/Fibrinolysis Parameters in the Development of Glomerulonephritis |
Q71877365 | Predictors of flares and long-term outcome of systemic lupus erythematosus during combined treatment with azathioprine and low-dose prednisolone |
Q34302895 | Problems with immunosuppressive agents in renal disease |
Q33987313 | Recent observations on central nervous system lupus erythematosus |
Q55215256 | Risk of adverse events from different drugs for SLE: a systematic review and network meta-analysis. |
Q35065278 | Steroid psychosis: a review |
Q53710420 | Systemic lupus erythematosus presenting as catatonic schizophrenia. |
Q39144775 | The differential diagnosis of crescentic glomerulonephritis. The pathology of specific lesions with prognostic implications |
Q38791636 | The treatment of lupus nephritis |
Q39749422 | The treatment of lupus nephritis |
Q40734777 | Thiamphenicol as an Immunosuppressant in Active Systemic Lupus Erythematosus with Nephritis |
Q24202572 | Treatment for lupus nephritis |
Q24247408 | Treatment for lupus nephritis |
Q42728756 | Treatment of lupus nephritis |
Q40906582 | Treatment of lupus nephritis: a meta-analysis of clinical trials |
Search more.